Sign In
Buy KURA
$8.66
-0.315 (-3.51%)
At Close: Jun 03, 2026
-$0.42 EPS Expected for Kura Oncology Inc (NASDAQ:KURA) This Quarter
10:10am, Saturday, 28'th Mar 2020
Brokerages expect Kura Oncology Inc (NASDAQ:KURA) to report earnings of ($0.42) per share for the current fiscal quarter, Zacks reports. Zero analysts have provided estimates for Kura Oncology’s ear
Algert Global LLC Takes Position in Kura Oncology Inc (NASDAQ:KURA)
08:28am, Friday, 27'th Mar 2020
Algert Global LLC acquired a new stake in shares of Kura Oncology Inc (NASDAQ:KURA) during the 4th quarter, Holdings Channel.com reports. The firm acquired 28,917 shares of the company’s stock, valu
Reviewing Kura Oncology (NASDAQ:KURA) and IntelGenx Technologies (NASDAQ:IGXT)
05:32am, Tuesday, 24'th Mar 2020
Kura Oncology (NASDAQ:KURA) and IntelGenx Technologies (OTCMKTS:IGXT) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 19.) * Biomerica, Inc. (NASDAQ: BMRA) * Centogene NV (
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 19.)
Biomerica, Inc. (NASDAQ...
The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection
12:00am, Thursday, 19'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on March 18)
Biomerica, Inc. (NASDAQ...
Kura Oncology (KURA) Received its Third Buy in a Row
11:31pm, Tuesday, 17'th Mar 2020
After Cowen & Co. and Piper Sandler gave Kura Oncology (NASDAQ: KURA) a Buy rating last month, the company received another Buy, this time from
Kura Oncology (KURA) Received its Third Buy in a Row
11:31pm, Tuesday, 17'th Mar 2020
After Cowen & Co. and Piper Sandler gave Kura Oncology (NASDAQ: KURA) a Buy rating last month, the company received
Barclays PLC Has $484,000 Stake in Kura Oncology Inc (NASDAQ:KURA)
09:34am, Sunday, 15'th Mar 2020
Barclays PLC lifted its stake in shares of Kura Oncology Inc (NASDAQ:KURA) by 106.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The
Kura Oncology Inc (NASDAQ:KURA) Receives Consensus Rating of "Buy" from Brokerages
06:18am, Saturday, 14'th Mar 2020
Kura Oncology Inc (NASDAQ:KURA) has earned a consensus rating of “Buy” from the twelve brokerages that are presently covering the stock, Marketbeat reports. One research analyst has rated the stoc
KBC Group NV Has $67,000 Stake in Kura Oncology Inc (NASDAQ:KURA)
08:36am, Friday, 13'th Mar 2020
KBC Group NV raised its stake in shares of Kura Oncology Inc (NASDAQ:KURA) by 104.2% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 4,850 shares of the com
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 12.)
Masimo...
The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO
12:00am, Thursday, 12'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on March 11)
Bicycle Therapeutics...
Kura Oncology Inc (NASDAQ:KURA) Shares Purchased by Capital Impact Advisors LLC
09:48am, Wednesday, 11'th Mar 2020
Capital Impact Advisors LLC boosted its holdings in Kura Oncology Inc (NASDAQ:KURA) by 8.2% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange
Driehaus Capital Management LLC Cuts Stake in Kura Oncology Inc (NASDAQ:KURA)
10:36am, Tuesday, 10'th Mar 2020
Driehaus Capital Management LLC lowered its position in shares of Kura Oncology Inc (NASDAQ:KURA) by 91.4% during the 4th quarter, according to the company in its most recent disclosure with the Secur
